No. |
著者名 |
演題名 |
掲載誌名 |
号 |
ページ |
年 |
1 |
Miyazaki S, Okazaki K, Tsuji M and Yamaguchi K |
Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models |
Antimicrob Agents Chemother |
48 |
378-383 |
2004 |
2 |
Matsumoto T, Nieuwenhuis EE, Cisneros RL, Ruiz-Perez B, Yamaguchi K, Blumberg RS and Onderdonk AB |
Protective effect of ethyl-3-(3-dimethyl aminopropyl) urea dihydrochloride (EDU) against LPS-induced death in mice |
J Med Microbiol |
53 |
97-102 |
2004 |
3 |
Kodaka K, Uesaka Y and Kashitani F |
Nissui glucose fermentative gram-negative rod identification system EB-20 gives a unique profile for typical nonsorbitol fermenting Escherichia coli O157:H7 |
J Clin Microbiol |
42 |
354-358 |
2004 |
4 |
Miyazaki S, Ishikawa F, Fujikawa T, Nagata S and Yamaguchi K |
Intaraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr1high polymophonuclear neutrophils in the murine abdominal cavity |
Clin Diagn Lab Immunol |
11 |
452-457 |
2004 |
5 |
Tateda K, Standiford TJ, Pechere JC and Yamaguchi K |
Regulatory effects of macrolides on bacterial virulence:Potential role as quorum-sensing inhibitors |
Current Pharmaceutical Design |
10 |
3055-3065 |
2004 |
6 |
Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ and Yamaguchi K |
Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-alpha |
J Med Microbiol |
53 |
1-7 |
2004 |
7 |
Kimura S, Ishiguro M, Ishii Y, Alba J and Yamaguchi K |
Role of a mutational substitution at position 167 of CTXM-19 in ceftazidime hydrolysis |
Antimicrob Agents Chemother |
48 |
1454-1460 |
2004 |
8 |
Suzuki K, Matsumoto T, Murakami H, Tateda K, Ishii N and Yamaguchi K |
Evaluation of a rapid antigen detection test for Neisseria gonorrhoeae in urine sediment for diagnosis of gonococcal urethritis in males |
J Infect Chemother |
10 |
208-211 |
2004 |
9 |
Ma L, Alba J, Chang FY, Ishiguro M, Yamaguchi K, Siu LK and Ishii Y |
Novel SHV-derived extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin |
Antimicrob Agents Chemother |
2 |
600-605 |
2004 |
10 |
Miyashita N, Yamaguchi K, Saito A, Kohno S, Watanabe A, Oda H, Kazuyama Y and Matsushima T |
Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia |
Resp Med |
98 |
542-550 |
2004 |
11 |
Kobayashi I, Yamaguchi K, Muraoka H, Iyoda T, Nishida M and Hasegawa M |
Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK2 system and comparison with two NCCLS reference methods |
J Med Microbiol |
53 |
1229-1232 |
2004 |
12 |
Yoshizumi S, Takahashi Y, Watanabe Y, Okezaki E, Ishii Y and Tateda K |
In vitro antibacterial activities of new fluoroquinolones against clinical isolates of Haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC |
Chemotherapy |
50 |
265-275 |
2004 |
13 |
Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB and Standiford TJ |
Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection |
Am J. Respir Crit Care Med |
170 |
1331-1339 |
2004 |
14 |
Ohno N, Fukuda H, Kimura S, Kim HW, Takahashi H, Amachi S, Shinoyama H and Fujii T |
Purification and properties of xylan degrading enzymes produced by Penicillium expansum O-385-10 concerning spoilage of apple fruit |
Jpn J Food Micribiol |
21 |
260-268 |
2004 |
15 |
Miyazaki S |
Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis |
J Infect Chemother |
10 |
135 |
2004 |